News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
154 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33091)
2026 (14411)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3141)
September (3205)
October (3539)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Business
Cambridge Epigenetix Appoints Professor Mark Dawson as Scientific Advisor
The appointment further strengthens CEGX’s panel of opinion leaders providing expert advice across the Company’s key focus areas of epigenetics, oncology, liquid biopsy, diagnostic and therapeutic development.
November 27, 2017
·
2 min read
Drug Development
Pivotal Trial Data Support Potential of Seno Medical Instruments’ Imagio Opto-Acoustic Breast Imaging System in Reducing False Positive Breast Examinations and Benign Biopsies
The study found that OA/US was more specific than device gray-scale ultrasound alone in differentiating malignant from benign breast lesions and was non-inferior to US with respect to sensitivity.
November 27, 2017
·
6 min read
Biotech Beach
San Diego’s Biolinq Scores $10M Series A
Biolinq’s first commercial product will allow patients with diabetes to continuously monitor their blood glucose without the pain and hassle of traditional continuous glucose monitoring systems.
November 27, 2017
·
3 min read
Business
Biogen Forges $278M MS Tie-Up With Alkermes
Biogen will receive an exclusive, worldwide license to commercialize ALKS 8700 and will pay Alkermes a mid-teens royalty on worldwide net sales of ALKS 8700.
November 27, 2017
·
12 min read
Drug Development
Kalytera Announces Second U.S. Patent for Prevention and Treatment of Graft Versus Host Disease
Kalytera’s Phase 2 study is expected to enroll 36 patients following allogeneic hematopoietic cell transplantation (“HCT”), commonly referred to as bone marrow transplantation.
November 27, 2017
·
5 min read
Policy
Benitec Biopharma Provides Update on OPMD Orphan Disease Program
In addition, over the past several weeks, the Benitec team has now completed pre-IND and scientific advice meetings with the U.S. FDA, Health Canada and several European agencies.
November 27, 2017
·
6 min read
BioMidwest
Sigmascreening Showcases Sensitive Sigma Paddle at RSNA
Based on breast-size and tissue-stiffness the Sensitive Sigma Paddle calculates the pressure to achieve an optimal compression of 75mmHg and allows for a highly reproducible procedure.
November 27, 2017
·
3 min read
Drug Development
Eureka Announces FDA Allowance of Investigational New Drug Application for ET190L1-ARTEMIS™ T cell Therapy in Relapsed and Refractory CD19+ Non-Hodgkin Lymphoma
In preclinical studies, ET190L1-ARTEMIS matched the cancer killing potency of current CAR-T therapies but with a dramatic reduction in the levels of inflammatory cytokines released
November 27, 2017
·
3 min read
Policy
Sobi Receives Approval From Health Canada for Orfadin (nitisinone) Oral Suspension for the Treatment of HT-1
Orfadin is the first medicine approved in multiple countries globally for use in combination with dietary restriction of tyrosine and phenylalanine in the treatment of hereditary tyrosinemia type 1 (HT-1).
November 27, 2017
·
3 min read
Business
Materialise and Siemens Healthineers syngo.via Partner to Bring 3D Printing to Hospitals Worldwide
The partnership makes Materialise Mimics inPrint software, a dedicated solution for printing anatomical models in hospitals, available to radiologists through the Siemens Healthineers syngo.via open app platform.
November 27, 2017
·
4 min read
Previous
7 of 16
Next